Related Experiment Video
Updated: May 29, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma
D Buitrago1, X M Keutgen, M Crowley
1Division of Endocrine and Minimally Invasive Surgery, Department of Surgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA.
Intercellular adhesion molecule-1 (ICAM-1) is upregulated in papillary thyroid cancer (PTC). Higher ICAM-1 levels correlate with aggressive features like BRAF V600E mutation and lymph node metastasis, indicating its role in PTC progression.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Intercellular adhesion molecule-1 (ICAM-1) is recognized for its role in carcinogenesis.
- This study investigates ICAM-1 expression in papillary thyroid cancer (PTC).
- The hypothesis posits a correlation between ICAM-1 and indicators of PTC aggressiveness.
Purpose of the Study:
- To determine ICAM-1 expression levels in PTC compared to benign thyroid conditions.
- To investigate the association between ICAM-1 expression and established markers of tumor aggressiveness in PTC.
Main Methods:
- Quantitative reverse-transcription polymerase chain reaction (RT-PCR) for ICAM-1 gene expression analysis.
- Immunohistochemistry (IHC) for semiquantitative assessment of ICAM-1 protein levels.
- Correlation analysis of ICAM-1 levels with BRAF V600E mutation, tumor size, extrathyroidal extension (ETE), angiolymphatic invasion, and lymph node metastasis.
Main Results:
- ICAM-1 gene expression was significantly higher in PTC and lymph node metastases compared to benign tissues.
- Elevated ICAM-1 levels were associated with BRAF V600E mutation, ETE, and lymph node metastasis in PTC.
- A positive correlation was observed between ICAM-1 gene expression and protein levels, with poorly differentiated carcinoma showing higher ICAM-1 intensity.
Conclusions:
- ICAM-1 expression is demonstrably upregulated in papillary thyroid carcinoma.
- ICAM-1 upregulation is linked to aggressive tumor characteristics, including BRAF V600E mutation, ETE, and lymph node metastasis.
- These findings suggest ICAM-1 plays a significant role in the progression of thyroid cancer.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Intracellular Signaling Affects Focal Adhesions
Some...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Cancer Cell Migration through Invadopodia
